Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Birrell

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Pharmacology & Therapeutics|March 23, 2011
The role of the NLRP3 inflammasome in the pathogenesis of airway diseaseMark A Birrell, Suffwan Eltom
The European Respiratory Journal|August 5, 2017
The emerging role of transient receptor potential channels in chronic lung diseaseMaria G Belvisi, Mark A Birrell
British Journal of Pharmacology|May 21, 2011
At last, a truly selective EP₂ receptor antagonistMark A Birrell, Anthony T Nials
Pharmacology & Therapeutics|November 16, 2010
Moving towards a new generation of animal models for asthma and COPD with improved clinical relevanceChristopher S Stevenson, Mark A Birrell
Current Protocols in Pharmacology|March 5, 2013
Cigarette smoke exposure as a model of inflammation associated with COPDSuffwan Eltom, Christopher Stevenson, Mark A Birrell
Chest|October 6, 2011
Transient receptor potential A1 channels: insights into cough and airway inflammatory diseaseMaria G Belvisi, Eric Dubuis, Mark A Birrell
Respiratory Research|August 5, 2009
MMP/TIMP expression profiles in distinct lung disease models: implications for possible future therapiesSissie Wong, Maria G Belvisi, Mark A Birrell
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 13, 2004
New advances and potential therapies for the treatment of asthmaMaria G Belvisi, David J Hele, Mark A Birrell
Expert Opinion on Therapeutic Targets|July 23, 2004
New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary diseaseMaria G Belvisi, David J Hele, Mark A Birrell
European Journal of Pharmacology|February 7, 2006
Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammationMaria G Belvisi, David J Hele, Mark A Birrell
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Pharmacology & Therapeutics|March 23, 2011
The role of the NLRP3 inflammasome in the pathogenesis of airway diseaseMark A Birrell, Suffwan Eltom
The European Respiratory Journal|August 5, 2017
The emerging role of transient receptor potential channels in chronic lung diseaseMaria G Belvisi, Mark A Birrell
British Journal of Pharmacology|May 21, 2011
At last, a truly selective EP₂ receptor antagonistMark A Birrell, Anthony T Nials
Pharmacology & Therapeutics|November 16, 2010
Moving towards a new generation of animal models for asthma and COPD with improved clinical relevanceChristopher S Stevenson, Mark A Birrell
Current Protocols in Pharmacology|March 5, 2013
Cigarette smoke exposure as a model of inflammation associated with COPDSuffwan Eltom, Christopher Stevenson, Mark A Birrell
Chest|October 6, 2011
Transient receptor potential A1 channels: insights into cough and airway inflammatory diseaseMaria G Belvisi, Eric Dubuis, Mark A Birrell
Respiratory Research|August 5, 2009
MMP/TIMP expression profiles in distinct lung disease models: implications for possible future therapiesSissie Wong, Maria G Belvisi, Mark A Birrell
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 13, 2004
New advances and potential therapies for the treatment of asthmaMaria G Belvisi, David J Hele, Mark A Birrell
Expert Opinion on Therapeutic Targets|July 23, 2004
New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary diseaseMaria G Belvisi, David J Hele, Mark A Birrell
European Journal of Pharmacology|February 7, 2006
Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammationMaria G Belvisi, David J Hele, Mark A Birrell
Pageof 8